Figure 4.
Figure 4. Outcome of children with SR B-ALL enrolled in COG AALL0331. (A) Kaplan-Meier estimates of EFS and OS of patients with Ph-like ALL compared with non Ph-like ALL (including ETV6-RUNX1, excluding BCR-ABL1). (B) Kaplan-Meier estimates of positive (≥0.01%) vs negative MRD (<0.01%) at end of induction for patients with Ph-like ALL (top) and non Ph-like ALL (bottom).

Outcome of children with SR B-ALL enrolled in COG AALL0331. (A) Kaplan-Meier estimates of EFS and OS of patients with Ph-like ALL compared with non Ph-like ALL (including ETV6-RUNX1, excluding BCR-ABL1). (B) Kaplan-Meier estimates of positive (≥0.01%) vs negative MRD (<0.01%) at end of induction for patients with Ph-like ALL (top) and non Ph-like ALL (bottom).

Close Modal

or Create an Account

Close Modal
Close Modal